Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi.
about
Getting to 90-90-90 in paediatric HIV: What is needed?The role of implementation science training in global health: from the perspective of graduates of the field's first dedicated doctoral program.Factors influencing postnatal Option B+ participation and breastfeeding duration among HIV-positive women in Lilongwe District, Malawi: A qualitative study.PMTCT Service Uptake Among Adolescents and Adult Women Attending Antenatal Care in Selected Health Facilities in Zimbabwe."If my husband leaves me, I will go home and suffer, so better cling to him and hide this thing": The influence of gender on Option B+ prevention of mother-to-child transmission participation in Malawi and UgandaExploring factors associated with ART adherence and retention in care under Option B+ strategy in Malawi: A qualitative study.Health facility factors and quality of services to prevent mother-to-child HIV transmission in Côte d'Ivoire, Kenya, and Mozambique.Implementation Research for the Prevention of Mother-to-Child HIV Transmission in Sub-Saharan Africa: Existing Evidence, Current Gaps, and New Opportunities.Early ART initiation among HIV-positive pregnant women in central Mozambique: a stepped wedge randomized controlled trial of an optimized Option B+ approach.Supporting Option B+ scale up and strengthening the prevention of mother-to-child transmission cascade in central Malawi: results from a serial cross-sectional study.Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, Malawi.Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.Self-Reported Side Effects and Adherence to Antiretroviral Therapy in HIV-Infected Pregnant Women under Option B+: A Prospective StudyOutcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial.90-90-90--Charting a steady course to end the paediatric HIV epidemic.Fundamental concerns of women living with HIV around the implementation of Option B+.Paediatric HIV: Progress on Prevention, Treatment and CureFactors associated with loss to follow-up among women in Option B+ PMTCT programme in northeast Ethiopia: a retrospective cohort study.Sexual and reproductive health and human rights of women living with HIV.Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort studyImplementation and Operational Research: Impact of a Systems Engineering Intervention on PMTCT Service Delivery in Côte d'Ivoire, Kenya, Mozambique: A Cluster Randomized Trial.HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.Retention in Care among HIV-Infected Pregnant Women in Haiti with PMTCT Option B.Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ ProgramFactors Associated with PMTCT Cascade Completion in Four African Countries.Evaluation of a Systems Analysis and Improvement Approach to Optimize Prevention of Mother-To-Child Transmission of HIV Using the Consolidated Framework for Implementation Research.Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi.Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.CLINICAL outcomes and loss to follow-up among people living with HIV participating in the NAMWEZA intervention in Dar es Salaam, Tanzania: a prospective cohort study.Understanding data sources to measure patient retention in HIV care in sub-Saharan Africa.Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa.A Novel Combined Mother-Infant Clinic to Optimize Post-Partum Maternal Retention, Service Utilization, and Linkage to Services in HIV Care in Rural RwandaHIV testing uptake and retention in care of HIV-infected pregnant and breastfeeding women initiated on 'Option B+' in rural Zimbabwe.Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.Moving toward test and start: learning from the experience of universal antiretroviral therapy programs for HIV-infected pregnant/ breastfeeding women.HIV treatment and care services for adolescents: a situational analysis of 218 facilities in 23 sub-Saharan African countries.Factors associated with retention in Option B+ in Malawi: a case control study.Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project Experience.
P2860
Q30385352-75135EAE-2298-4104-B506-2D9F20E5F352Q30395232-742C6B9A-A14D-4BB2-ABA3-AD7A897E942BQ33565528-1A7F50CF-BBBA-49C0-A787-5E22EA49D562Q33669862-160CB7EE-6E83-441B-84D4-610A15E331C4Q33778400-BEA4C3DE-5F99-458C-9820-C66C8BB896B1Q33821909-50816B26-D86C-40C6-8394-E2F6AF0DDB64Q33908206-1CAF5082-352E-4526-961C-3A2A3F6FA9B2Q35602506-F4538ED8-C990-4965-B807-450C85FC95ACQ35620337-61292792-79E5-4DA5-8A11-F0D081E58BA7Q35743290-F2C51B93-7574-431A-9702-DA1D2F069815Q35931175-4999811C-C259-4AF2-AFFE-EDE3B71F5F4AQ36094052-094A38D7-B21A-41C1-B8A3-AED5AD841C35Q36167659-671BE30D-B799-4932-8991-C0E1AD880E28Q36187496-3FFF61D7-5BB4-4C2B-8E6C-99095FADB86DQ36313626-2A8DF2B0-5154-4A8B-92C8-60D0E606C703Q36349696-F4CA7B27-80B5-4E31-92D6-5D28A5B4E978Q36353990-836D7F23-D483-434D-B83F-B4AAC87E77D8Q36395153-F8E9F165-377D-4AFA-BA96-5EA4752B4096Q36717889-99283137-59B4-41BD-A51B-94037E24841AQ36744865-2D097261-60A7-463A-A2B3-551B117306DAQ36995825-22AEE675-0950-4938-8DB2-81DD7AF4A729Q37014059-69A9B5FC-0D81-49D0-A0E4-21E583A044C2Q37014520-FBC971FF-06D1-410D-A02E-7AF6D0C22DE9Q37249851-B1169A1B-0CEE-4C0B-8AFE-ADA87312477DQ37339299-6211BAA5-F6B1-4392-BA58-A6E33E91922DQ37411580-1EFA13ED-131E-49E0-990E-74D120C3478CQ37420098-68BC1774-BEA4-4BB0-BF93-2268F179068BQ37685149-FD0738EE-09D8-4CA6-896C-16D53AA51616Q37712861-B84B948F-A7F2-4B5D-B0B3-AF80E5335868Q37726969-DD09BEE6-4022-458B-8C41-425B3BC36215Q38372160-A147366D-859A-4098-95B5-0A701648FB52Q38380464-67D752A9-5FA7-431F-95E8-C6FFA8AF9612Q38629435-3699A20A-C0CE-442F-9B90-87ADFCD01A24Q38629708-74D75B68-996A-44DE-8203-2BD8F48D5DF5Q38647745-4A86AEF7-EF1A-4218-8C3F-B43E20272568Q38661915-B48AD3D7-6E79-4D3E-B963-FB0FA2131ECDQ38748609-75556A63-6EEA-4DE3-8E13-F1B8F84D1BB9Q38771862-3F5FB28B-2176-422C-83C7-5F6987940BB2Q38814822-C52C9B66-8188-4292-83C1-0C350F0A8FFEQ38851836-EA89794C-536F-4B98-840B-E915D035D961
P2860
Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Understanding factors, outcome ...... programme in Lilongwe, Malawi.
@en
Understanding factors, outcome ...... programme in Lilongwe, Malawi.
@nl
type
label
Understanding factors, outcome ...... programme in Lilongwe, Malawi.
@en
Understanding factors, outcome ...... programme in Lilongwe, Malawi.
@nl
prefLabel
Understanding factors, outcome ...... programme in Lilongwe, Malawi.
@en
Understanding factors, outcome ...... programme in Lilongwe, Malawi.
@nl
P2093
P2860
P356
P1476
Understanding factors, outcome ...... programme in Lilongwe, Malawi.
@en
P2093
Annie Chauma
Colin Speight
Hannock Tweya
Janet Chikonda
Malocho Phoso
Mina Hosseinipour
Mphatso Bokosi
Patricia Khomani
Tiwonge Mtande
P2860
P304
P356
10.1111/TMI.12369
P50
P577
2014-08-04T00:00:00Z